|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM162218710 |
| 003 |
DE-627 |
| 005 |
20231223093806.0 |
| 007 |
tu |
| 008 |
231223s2005 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0541.xml
|
| 035 |
|
|
|a (DE-627)NLM162218710
|
| 035 |
|
|
|a (NLM)16637097
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Novel heart failure drug may offer options for you
|
| 264 |
|
1 |
|c 2005
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 25.04.2006
|
| 500 |
|
|
|a Date Revised 07.12.2022
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a News
|
| 650 |
|
7 |
|a Drug Combinations
|2 NLM
|
| 650 |
|
7 |
|a Vasodilator Agents
|2 NLM
|
| 650 |
|
7 |
|a isosorbide-hydralazine combination
|2 NLM
|
| 650 |
|
7 |
|a Hydralazine
|2 NLM
|
| 650 |
|
7 |
|a 26NAK24LS8
|2 NLM
|
| 650 |
|
7 |
|a Isosorbide Dinitrate
|2 NLM
|
| 650 |
|
7 |
|a IA7306519N
|2 NLM
|
| 773 |
0 |
8 |
|i Enthalten in
|t Heart advisor
|d 1999
|g 8(2005), 9 vom: 19. Sept., Seite 2
|w (DE-627)NLM098274252
|x 1523-9004
|7 nnns
|
| 773 |
1 |
8 |
|g volume:8
|g year:2005
|g number:9
|g day:19
|g month:09
|g pages:2
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 8
|j 2005
|e 9
|b 19
|c 09
|h 2
|